Renaissance Capital logo

IPO News & Commentary

Get the latest insights on new stocks

Antibody biotech Electra Therapeutics prices upsized IPO at $15 midpoint

Electra Therapeutics logo

Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, raised $350 million by offering 23.3 million shares at $15, within the $14 to $16 range. The company originally filed to offer 21.6 million shares at...read more

E&S home insurer Orion180 Insurance Group prices IPO at $12, below the range

Orion180 Insurance Group logo

Orion180 Insurance Group, which provides excess & surplus (E&S) home insurance concentrated in the US Southeast, raised $240 million by offering 20 million shares at $12, below the $15 to $17 range. At the pricing, the company has a diluted market value ...read more

Livestreaming platform C2 Capital Group withdraws $17 million IPO

C2 Capital Group logo

C2 Capital Group, which operates a livestreaming platform with built-in gifting tools, withdrew its plans for an initial public offering on Thursday. It had filed in April 2026 to raise $17 million by offering 3.8 million shares at a price range of $4 to $5. ...read more

IPO News By Industry

Be the in-house IPO Expert

Our clients are focused on catalyzing growth and creating value.

Not scouring the web for IPO data.

Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.